risedronic acid has been researched along with Fractures, Periprosthetic in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leclerc, JT | 1 |
| Michou, L | 1 |
| Vaillancourt, F | 1 |
| Pelet, S | 1 |
| Simonyan, D | 1 |
| Belzile, EL | 1 |
| Sköldenberg, OG | 1 |
| Salemyr, MO | 1 |
| Bodén, HS | 1 |
| Ahl, TE | 1 |
| Adolphson, PY | 1 |
2 trials available for risedronic acid and Fractures, Periprosthetic
| Article | Year |
|---|---|
Prevalence and Characteristics of Atypical Periprosthetic Femoral Fractures.
Topics: Aged; Aged, 80 and over; Alendronate; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2019 |
The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Aged; Analysis of Variance; Arthroplasty, Repla | 2011 |